Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
2019 · Trials · 205 citations
https://doi.org/10.1186/s13063-019-3259-x
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
336
Citations
4
h-index
4
i10-index
Gail Busza is an academic researcher from Hammersmith Hospital. The author has contributed to research in topics: Diabetes Treatment and Management & Alzheimer's disease research and treatments & Dementia and Cognitive Impairment Research. The author has an h-index of 4, co-authored 5 publications.
https://doi.org/10.1186/s13063-019-3259-x
https://doi.org/10.1186/s13063-020-04608-4
Click to start Chat